Pharmacogenomics

Pharmacogenetics and pharmacogenomics of therapeutic monoclonal antibodies
pp. 961-964(4)
Authors: Yan, Li; Davis, Hugh M

Biomarkers to improve cancer detection
pp. 965-967(3)

Human Variome Project: an international collaboration to catalogue human genetic variation
pp. 969-972(4)
Authors: Ring, Huijun Z; Kwok, Pui-Yan; Cotton, Richard GH

Development and clinical evaluation of oligonucleotide microarray for HLA-AB genotyping
pp. 973-985(13)
Authors: Zhang, Fan; Hu, Shouwang; Huang, Jian; Wang, Hui; Wen, Zheng; Yongyao, Geng; Wang, Shengqi

Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients
pp. 987-993(7)
Authors: Xing, Qinghe; Gao, Rui; Li, Huafang; Feng, Guoyin; Xu, Mingqing; Duan, Shiwei; Meng, Junwei; Zhang, Aiping; Qin, Shengying; He, Lin

Pyrosequencing™-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance
pp. 995-1002(8)
Authors: Rohrbacher, Maren; Kirchhof, Anja; Geisslinger, Gerd; Lötsch, Jörn

Toxicogenomics strategies for predicting drug toxicity
pp. 1003-1016(14)
Authors: Martin, Rory; Rose, David; Yu, Kai; Barros, Scott

An artificial neural network approach to the drug efficacy of interferon treatments
pp. 1017-1024(8)
Authors: Lin, Eugene; Hwang, Yuchi; Wang, Shu-Ching; Gu, Z John; Chen, Ellson Y

Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix^® database
pp. 1025-1044(20)
Authors: Ganter, Brigitte; Snyder, Ronald D; Halbert, Donald N; Lee, May D

Perspectives on development of a combination pharmacogenomic diagnostic and drug product
pp. 1045-1049(5)
Authors: McCamish, Mark; Izumi, Raquel

Metabolomics Special Focus: an introduction
pp. 1053-1054(2)
Author: Schnackenberg, Laura K

Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
pp. 1055-1075(21)
Authors: Schlotterbeck, Götz; Ross, Alfred; Dieterle, Frank; Senn, Hans

Monitoring the health to disease continuum with global metabolic profiling and systems biology
pp. 1077-1086(10)
Authors: Schnackenberg, Laura K; Beger, Richard D

Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?
pp. 1087-1094(8)
Authors: van der Greef, Jan; Hankemeier, Thomas; McBurney, Robert N

Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders
pp. 1095-1107(13)
Authors: Griffin, Julian L; Nicholls, Andrew W

Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
pp. 1109-1123(15)
Authors: Glunde, Kristine; Serkova, Natalie J